ˌɔn ˈɔːɡəst fˈɪftiːn, tˈuː θˈaʊzənd θˈɜːtiːn ðɪ ˌɛfdˌiːˈeɪ ˈɪʃuːd ɐ sˈeɪfti ɐnˈaʊnsmənt wˌɛɹ ðeɪ dᵻskɹˈaɪbd ðæt ðeɪ ɑːɹ ɹᵻkwˈaɪɚɹɪŋ ðə mˌɛdɪkˈeɪʃən ɡˈaɪdz ænd dɹˈʌɡ lˈeɪbəlz fɔːɹ ˈɔːl flˈʊɹɹəkwˌɪnəlˌoʊnz təbi ʌpdˈeɪɾᵻd ænd bˈɛɾɚ dᵻskɹˈaɪb ðə ɹˈɪsk fɔːɹ pɚɹˈɪfɚɹəl nʊɹɹˈɑːpəθi.
On August 15, 2013 the FDA issued a Safety Announcement where they described that they are requiring the medication guides and drug labels for all fluoroquinolones to be updated and better describe the risk for peripheral neuropathy.